ES2106319T3 - Uso de lactoferrina en la fabricacion de un medicamento para el tratamiento del reumatismo. - Google Patents

Uso de lactoferrina en la fabricacion de un medicamento para el tratamiento del reumatismo.

Info

Publication number
ES2106319T3
ES2106319T3 ES93901738T ES93901738T ES2106319T3 ES 2106319 T3 ES2106319 T3 ES 2106319T3 ES 93901738 T ES93901738 T ES 93901738T ES 93901738 T ES93901738 T ES 93901738T ES 2106319 T3 ES2106319 T3 ES 2106319T3
Authority
ES
Spain
Prior art keywords
rheumatism
treatment
lactoferrin
manufacture
medicinal product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93901738T
Other languages
English (en)
Inventor
Mitsushi Hikida
Masaaki Hayashi
Michel Francois Degre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Serae Laboratoires SA
Original Assignee
Bio Serae Laboratoires SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11507338&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2106319(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bio Serae Laboratoires SA filed Critical Bio Serae Laboratoires SA
Application granted granted Critical
Publication of ES2106319T3 publication Critical patent/ES2106319T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION CONCIERNE A UN AGENTE TERAPEUTICO PARA EL REUMATISMO QUE CONTIENE LACTOFERRINA COMO INGREDIENTE ACTIVO. DICHO AGENTE TERAPEUTICO MUESTRA UN EXCELENTE EFECTO INHIBIDOR CONTRA LA ACTIVIDAD DE LA COLAGENASA Y ES UTIL PARA EL TRATAMIENTO DEL REUMATISMO.
ES93901738T 1992-01-08 1993-01-06 Uso de lactoferrina en la fabricacion de un medicamento para el tratamiento del reumatismo. Expired - Lifetime ES2106319T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP00164892A JP3184923B2 (ja) 1992-01-08 1992-01-08 抗リウマチ剤

Publications (1)

Publication Number Publication Date
ES2106319T3 true ES2106319T3 (es) 1997-11-01

Family

ID=11507338

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93901738T Expired - Lifetime ES2106319T3 (es) 1992-01-08 1993-01-06 Uso de lactoferrina en la fabricacion de un medicamento para el tratamiento del reumatismo.

Country Status (5)

Country Link
EP (1) EP0620737B1 (es)
JP (1) JP3184923B2 (es)
DE (1) DE69313261T2 (es)
ES (1) ES2106319T3 (es)
WO (1) WO1993013790A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ500712A (en) * 1997-04-10 2002-10-25 Agennix Inc Use of a lactoferin product to inhibit the inflammatory activity of interleukin-1 beta in the treatment of allergen-induced inflammatory disorders
AU9028498A (en) 1997-08-22 1999-03-16 Deka Products Limited Partnership System, method and cassette for mixing and delivering intravenous drugs
AU5997801A (en) * 2000-05-15 2001-11-26 Canadian Inovatech, Inc. Compositions for the preservation of collagen and elastin
JP4592041B2 (ja) * 2000-11-24 2010-12-01 株式会社Ｎｒｌファーマ 生活の質を改善する新規食品の製造法および用途
US8399414B2 (en) 2002-01-21 2013-03-19 Nrl Pharma, Inc. Analgesics
PT1507554E (pt) * 2002-05-10 2011-11-21 Agennix Inc Lactoferrina no tratamento de neoplasmas malignos e outras doenças hiperproliferativas
EP1635766A4 (en) 2003-06-06 2009-09-30 Agennix Inc LACTOFERRIN AS ADJUVANS IN CANCER VACCINES
KR101242428B1 (ko) * 2005-03-15 2013-03-12 캄피나 네덜란드 홀딩 베.붸. 유즙 단백질의 피부학적 용도
JP2008189637A (ja) * 2007-02-08 2008-08-21 Snow Brand Milk Prod Co Ltd 自己免疫疾患予防剤
HRPK20110080B3 (hr) 2011-02-02 2014-01-03 Zdravko MAUKO Pripravak za lijeäśenje koštanih poremeä†aja i poremeä†aja zglobova

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0210204B1 (de) * 1985-01-18 1988-12-07 Kailash Kumar Dr. Prof. Gauri Proteinhydrolysate, verfahren zu ihrer herstellung und arzneimittel, die diese hydrolysate enthalten

Also Published As

Publication number Publication date
DE69313261T2 (de) 1998-03-26
DE69313261D1 (de) 1997-09-25
JP3184923B2 (ja) 2001-07-09
WO1993013790A1 (en) 1993-07-22
JPH05186368A (ja) 1993-07-27
EP0620737B1 (en) 1997-08-20
EP0620737A1 (en) 1994-10-26

Similar Documents

Publication Publication Date Title
ES2178048T3 (es) Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis.
ES2139132T3 (es) Composiciones farmaceuticas activas en la terapia de desordenes del sueño.
SE8503664L (sv) Ett system for tillforsel av lekemedel
DE69424546D1 (de) Thermoplastische elastomere copolymere und diese enthaltendes haar- und hautpflegemittel
ES2145836T3 (es) Copolimeros elastomericos termoplasticos injertados de silicona, y composiciones que los contienen para el cuidado del pelo y la piel.
ES2157601T3 (es) Uso de agentes anti-microtubulos para tratar o prevenir la esclerosis multiple.
ATE429904T1 (de) Topisch anwendbare arzneipräparate und verfahren zur behandlung
GR77254B (es)
ATE183528T1 (de) Thermoplastische elastomere copolymere und diese enthaltendes haar und hautflegemittel
MX9703621A (es) Nuevos derivados aminoacidos con actividad mejorada para la resistencia a drogas multiples.
ATE121627T1 (de) Verminderung oder verhütung der von arzneimitteln verursachten hautreizung.
ES2082198T3 (es) Inhibidores de esteroide-sulfatasa.
ES2116642T3 (es) Composicion farmaceutica para tratar la osteoporosis que contiene xantohumol.
ES2061989T3 (es) Uso de esteres alquilicos del acido piroglutamico para la fabricacion de un medicamento para el tratamiento de la ictiosis.
DE3271930D1 (en) Pharmaceutical preparation for the topical treatment of acne
MX9602973A (es) Uso de un antagonista de bradiquinina en una composicion, cosmetica, farmaceutica o dermatologica y la composicion obtenida.
ES2143467T3 (es) Agente terapeutico para el tratamiento de las heridas.
SE9701161D0 (sv) New use I
ES2149279T3 (es) Sistema terapeutico para el tratamiento de la psoriasis.
ES2125356T3 (es) Empleo de leflunomida para la inhibicion de interleuquina 8.
ES2177849T3 (es) Preparado farmaceutico, que contiene 2-fenil-1,2-benzoisoselenazol-3(2h)-ona, para el tratamiento de la enfermedad de alzheimer.
ES2159357T3 (es) Derivados terpenoides (sarcodictinas) utiles como agentes antitumorales.
SE8101374L (sv) Kompositioner innehallande n,n-dietyl-m-toluamid
ES2042818T3 (es) Agente terapeutico para la trombocitopenia.
MD1484F2 (ro) Aplicare a dimeticonei în calitate de ingredient activ în compoziţie farmaceutică pentru tratamentul constipaţiilor şi compoziţie farmaceutică conţinând dimeticonă

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 620737

Country of ref document: ES